LEI 549300Y0OI2WVUNHLC33
BioArctic AB
Group parent: Demban AB
Contract awards & public grants
From biophysical chemistry to cell biology: Deciphering the role of lipids in the toxicity and spreading of protein aggregation → BIOARCTIC AB
European Commission · SE · Grant · 2025-07-03
—
Novel brain health solutions across four focus areas: Prevention and care, Methods and data, Innovation and society, and Ethics and well-being → BIOARCTIC AB
European Commission · SE · Grant · 2024-08-05
—
PRECISION MEDICINE PLATFORM IN NEURODEGENERATIVE DISEASE → BIOARCTIC AB
European Commission · SE · Grant · 2023-04-25
—
PET Imaging of Alpha-Synuclein Fibril Formation → BIOARCTIC AB
European Commission · SE · Grant · 2018-08-30
€281,983
Validation of diagnostic and prognostic biomarkers for Parkinson disease → BIOARCTIC AB
European Commission · SE · Grant · 2015-08-19
€50,000
Regenerative treatment of complete Traumatic Spinal Cord injury with a surgical implantation of a biodegradable device with FGF1 and nerve grafts → BIOARCTIC AB
European Commission · SE · Grant · 2014-12-03
€652,987
Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.